Form 4: Intuitive Surgical Executive Sells Shares

Mark Brosius, EVP of Manufacturing and Supply Chain at Intuitive Surgical, sold 48 shares of common stock under a 10b5-1 plan.

Summary

• Mark Brosius, EVP & Chief Manufacturing and Supply Chain Officer, sold a total of 48 shares of Intuitive Surgical (ISRG) common stock.
• The sales occurred on June 11, 2026 (23 shares at $412.16) and June 12, 2026 (25 shares at $414.13).
• Following these transactions, the reporting person holds 1,406 shares of common stock.
• The transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed under a pre-planned 10b5-1 arrangement and represents a negligible portion of the executive's holdings.

Positives

• The sale was conducted under a pre-established Rule 10b5-1 trading plan, which is designed to avoid concerns regarding insider trading.

Negatives

• The sale represents a reduction in the executive's direct equity stake in the company.

Risks

• None identified in this filing.

Future Outlook

The filing does not provide forward-looking guidance, as it is a mandatory disclosure of insider transaction activity.

Industry Context

StockSavvy.ai notes that routine 10b5-1 sales by executives are standard corporate practice and generally do not signal a change in company fundamentals or management sentiment.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives to liquidate equity positions while maintaining regulatory compliance.

Stakeholder Impact

• Minimal impact on shareholders as the transaction volume is immaterial to the company's total outstanding shares.

Next Steps

• No further actions required by the reporting person other than continued compliance with SEC reporting requirements.

Key Dates

Keywords

ISRG, Intuitive Surgical, Insider Trading, Form 4, Stock Sale, 10b5-1